Author: admin
Dr. Andrea Georgiou delivers expert talk on smoking addiction biomarkers at KES College
We’re excited to announce that Dr. Andrea Georgiou, head of the Genetics Epidemiology Unit within the Zanos lab was invited to give a talk on her research on biomarkers associated with smoking addiction at KES College in Cyprus. The presentation focused on investigating biological indicators related to smoking dependence in the Cypriot population. Dr. Georgiou brings […]
Dr. Zanos was invited to discuss groundbreaking ketamine clinical trial on Cyprus Broadcasting Corporation
We are pleased to announce that Dr. Zanos was recently invited to appear on the Cyprus Broadcasting Corporation (RIK) to discuss our laboratory’s groundbreaking clinical trial investigating ketamine as a treatment for opioid use disorder (OUD). This pioneering study—the first of its kind in Cyprus—is being conducted at the “GEFYRA” (BRIDGE) Substitute Substance Unit in […]
New special issue led by our lab: Climate-Driven Effects on the Human Microbiome and Public Health
We’re excited to announce that our laboratory is leading a special issue in Microorganisms journal focusing on the intersection of climate change and the human microbiome. Dr. Zanos and Dr. Onisiforou are serving as Guest Editors for this initiative. Our special issue aims to explore how environmental changes affect human-associated microbial communities and their subsequent […]
The Zanos Lab welcomes our new Marie Skłodowska-Curie (Onisilos co-fund) fellow, Dr. Polymnia Louka!
We are excited to welcome Dr. Polymnia Louka to the Translational Neuropharmacology Lab as an ONISILOS Marie Skłodowska-Curie Fellow. Her research focuses on the effects of ketamine’s enantiomers and active metabolites on depression-induced bone impairment, aiming to uncover novel therapeutic interventions at the intersection of neuropharmacology, bone biology, and imaging. Dr. Louka has a diverse […]
Cover story feature: Zanos Lab’s groundbreaking paper on microbial influences in Alzheimer’s Disease
We are delighted to announce that our recent publication on microbial influences in Alzheimer’s disease has been selected for the cover story for Volume 13, Issue 1 (January 2025) of Microorganisms journal. This recognition by the journal highlights the significance and timeliness of our research in challenging traditional paradigms of Alzheimer’s Disease treatment. The cover […]
Public lecture on stress and mental health coordinated by Dr. Zanos
Dr. Panos Zanos coordinated a public lecture on stress and mental health on January 23rd at the Salaminio Free/Open University of Famagusta. The event featured presentations by Dr. Maria Tsiarli, Ph.D. in Developmental Neurobiology, on “Stress and Nervous System Health,” and Professor Georgia Panayiotou, Dean of the Graduate School at the University of Cyprus, on […]
Our postdoctoral fellow, Dr. Andria Michael, awarded a YUFE4Postdocs fellowship with €167,880 in funding
We are excited to announce that Dr. Andria Michael, a postdoctoral fellow in the Zanos Lab, has been awarded the highly competitive YUFE4Postdocs Fellowship, co-funded by the European Union’s Marie Skłodowska-Curie Actions (MSCA) program. This fellowship provides Dr. Michael with a 26-month research position at the University of Cyprus, offering exceptional training opportunities and a […]
New Publication from the Zanos Lab led by Dr. Anna Onisiforou: Microbial Influences in Alzheimer’s Disease
For decades, Alzheimer’s disease (AD) research has been dominated by the amyloid cascade hypothesis, which positions amyloid-beta (Aβ) accumulation as the primary driver of the disease. However, the consistent failure of Aβ-targeted therapies to demonstrate efficacy, coupled with significant safety concerns, has underscored the critical need to rethink our approach to AD treatment. In our […]
Zanos Laboratory secures major grant funding of €600,000
We are delighted to announce that the Zanos Laboratory has secured €600,000 in research funding by the Research and Innovation Foundation, to support several innovative research programs in neuroscience and mental health. This funding will enable our laboratory to pursue multiple distinct lines of investigation that address important questions in mental health research. In collaboration […]
Dr. Zanos presents groundbreaking research on novel therapeutic approaches for opioid addiction
We are pleased to announce that Dr. Zanos recently delivered an impactful presentation on innovative approaches to treating opioid addiction. The lecture highlighted cutting-edge research developments and provided insights into the PROUD study, a pioneering clinical trial investigating ketamine’s potential in preventing opioid relapse. During this enlightening session, Dr. Zanos shared important findings about the […]